Ambu A/S (OTCMKTS:AMBBY) Reaches New 1-Year Low – Here’s What Happened

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) shares hit a new 52-week low on Wednesday . The company traded as low as $10.80 and last traded at $10.80, with a volume of 101 shares traded. The stock had previously closed at $11.50.

Ambu A/S Trading Down 2.8%

The company has a current ratio of 2.86, a quick ratio of 1.67 and a debt-to-equity ratio of 0.08. The business has a 50 day moving average of $12.94 and a 200-day moving average of $14.01. The stock has a market cap of $2.54 billion, a PE ratio of 34.84 and a beta of 0.98.

Ambu A/S (OTCMKTS:AMBBY) last released its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.The company had revenue of $242.85 million during the quarter.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.